Paula S Azevedo Selected Research

Ventricular Remodeling

1/2017	Tomato (Lycopersicon esculentum) or lycopene supplementation attenuates ventricular remodeling after myocardial infarction through different mechanistic pathways.
12/2016	Green tea (Cammellia sinensis) attenuates ventricular remodeling after experimental myocardial infarction.
1/2015	Pamidronate attenuates diastolic dysfunction induced by myocardial infarction associated with changes in geometric patterning.
1/2013	Waist circumference, but not body mass index, is a predictor of ventricular remodeling after anterior myocardial infarction.
5/2012	Prevalence and predictors of ventricular remodeling after anterior myocardial infarction in the era of modern medical therapy.
1/2012	Aldosterone is not involved in the ventricular remodeling process induced by tobacco smoke exposure.
1/2011	Tobacco smoke induces ventricular remodeling associated with an increase in NADPH oxidase activity.
1/2010	Tissue vitamin A insufficiency results in adverse ventricular remodeling after experimental myocardial infarction.
7/2009	Role of lipoperoxidation in the remodeling intensification induced by beta-carotene after infarction.
6/2009	Effects of the administration of beta-blockers on ventricular remodeling induced by cigarette smoking in rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paula S Azevedo Research Topics

Disease

19	Myocardial Infarction 03/2022 - 09/2005
17	Ventricular Remodeling 01/2017 - 09/2005
10	Infarction (Infarctions) 01/2018 - 07/2009
7	Inflammation (Inflammations) 01/2021 - 12/2009
5	Heart Failure 08/2019 - 01/2012
4	Hypertrophy 06/2022 - 12/2012
4	Fibrosis (Cirrhosis) 01/2017 - 01/2012
3	Body Weight (Weight, Body) 01/2017 - 01/2015
3	Ventricular Dysfunction 06/2014 - 05/2010
2	Malnutrition (Nutritional Deficiencies) 01/2021 - 08/2019
2	Burns 08/2019 - 08/2016
2	Septic Shock (Toxic Shock Syndrome) 08/2019 - 06/2016
2	Cardiomegaly (Heart Hypertrophy) 04/2016 - 02/2013
2	Cardiomyopathies (Cardiomyopathy) 01/2014 - 01/2012
1	ST Elevation Myocardial Infarction 03/2022
1	Cardiotoxicity 01/2021
1	Protein-Energy Malnutrition (Marasmus) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Frailty 01/2021
1	Sarcopenia 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2019
1	Brain Diseases (Brain Disorder) 08/2019
1	Critical Illness (Critically Ill) 08/2019
1	Alcoholism (Alcohol Abuse) 08/2019
1	Refeeding Syndrome 08/2019
1	Beriberi 08/2019
1	Thyrotoxicosis 10/2014
1	Muscle Weakness 10/2014
1	Hypokalemic Periodic Paralysis (Periodic Paralysis, Hypokalemic) 10/2014
1	Hypokalemia 10/2014
1	Acidosis 05/2013
1	Hypovolemia 02/2013
1	Acne Vulgaris 02/2013
1	Pressure Ulcer (Bedsore) 01/2013
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2013
1	Suppuration 09/2012
1	Hip Fractures (Intertrochanteric Fractures) 09/2012
1	Dyspnea (Shortness of Breath) 05/2012
1	Hepatic Encephalopathy 02/2011

Drug/Important Bio-Agent (IBA)

12	SmokeIBA 01/2014 - 09/2005
7	salicylhydroxamic acid (SHAM)IBA 01/2018 - 05/2010
5	CollagenIBA 01/2018 - 01/2013
4	EnzymesIBA 01/2018 - 01/2011
4	Metalloproteases (Metalloproteinases)IBA 04/2013 - 01/2012
4	beta Carotene (Betacarotene)FDA Link 07/2009 - 09/2005
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2013
3	Thiamine (Aneurin)FDA Link 08/2019 - 07/2008
3	Matrix Metalloproteinases (MMPs)IBA 04/2013 - 12/2012
3	Creatine Kinase (Creatine Phosphokinase)IBA 04/2013 - 05/2012
2	TeaIBA 01/2021 - 12/2016
2	AntioxidantsIBA 01/2018 - 01/2011
2	CalciumIBA 01/2016 - 01/2015
2	Taurine FDA Link 10/2013 - 01/2012
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2013 - 10/2005
1	Tissue Inhibitor of Metalloproteinase-1IBA 06/2022
1	MyostatinIBA 03/2022
1	MicroRNAs (MicroRNA)IBA 01/2021
1	ZincIBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 01/2017
1	LycopeneIBA 01/2017
1	CytokinesIBA 01/2017
1	Calcitriol Receptors (Calcitriol Receptor)IBA 08/2016
1	SEW2871IBA 04/2016
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2016
1	SphingolipidsIBA 04/2016
1	Sphingosine-1-Phosphate ReceptorsIBA 04/2016
1	thermozymocidin (myriocin)IBA 04/2016
1	Contractile ProteinsIBA 01/2016
1	Corn Oil (Oil, Corn)IBA 11/2015
1	Pamidronate (Aredia)FDA LinkGeneric 01/2015
1	Vitamin D FDA LinkGeneric 10/2014
1	flopropioneIBA 10/2014
1	MB Form Creatine KinaseIBA 06/2014
1	IsoenzymesIBA 06/2014
1	PeriostinIBA 10/2013
1	Hydroxyproline (4 Hydroxyproline)IBA 10/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2013
1	Adenosine Triphosphate (ATP)IBA 05/2013
1	factor EF-PIBA 04/2013
1	Isotretinoin (Accutane)FDA LinkGeneric 02/2013
1	antineoplaston A10 (A 10)IBA 01/2013
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2012
1	Mitogen-Activated Protein KinasesIBA 12/2012
1	MicronutrientsIBA 01/2012
1	AldosteroneIBA 01/2012
1	Amino Acids FDA Link 01/2012
1	Branched-Chain Amino AcidsIBA 02/2011
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2011
1	A-factor (Streptomyces)IBA 05/2010
1	Vitamin A (Retinol)FDA LinkGeneric 01/2010
1	Lipoproteins (Lipoprotein)IBA 12/2009
1	Adrenergic Agents (Adrenergic Drugs)IBA 06/2009
1	Propranolol (Inderal)FDA LinkGeneric 06/2009

Therapy/Procedure

4	Therapeutics 06/2014 - 05/2012
2	Ligation 01/2015 - 01/2013
1	Subcutaneous Injections 01/2015
1	Length of Stay 09/2012